{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Lake Zurich",
      "address_1": "3 Corporate Dr",
      "reason_for_recall": "Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.",
      "address_2": "",
      "product_quantity": "15,625 vials",
      "code_info": "Lot #: 6103882, Exp 10/14",
      "center_classification_date": "20130823",
      "distribution_pattern": "Nationwide",
      "state": "IL",
      "product_description": "Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50",
      "report_date": "20130904",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Fresenius Kabi USA, LLC",
      "recall_number": "D-920-2013",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "65218",
      "termination_date": "20160310",
      "more_code_info": "",
      "recall_initiation_date": "20130525",
      "postal_code": "60047-8930",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}